NCT00015990
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
- Locations
-
- North Central Cancer Treatment Group Rochester, Minnesota, United States
Clinical trial condition
Refractory Anemia
Explore clinical trials studying Refractory Anemia. Study availability and eligibility vary by location and protocol.
24 public trials
1 recruiting study
Refractory Anemia trial results
NCT00002798
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
NCT00012376
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +46 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Active, Not Recruiting
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
NCT00392353
- Conditions
- Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
- North Shore University Hospital Manhasset, New York, United States
- Mount Sinai Hospital New York, United States